METHODS FOR PRODUCING A NEW GENERATION OF SAFETY FROM THE BIOLOGICAL POINT OF VIEW OF KLH PRODUCTS APPLICABLE FOR TREATING CANCER, FOR THE DEVELOPMENT OF CONJUGATED THERAPEUTIC VACCINES AND AS A STIMULANT

摘要

The present invention relates to the provision of a biologically safe hemolymph sera, preferably hemocyanin, more preferably KLH (keyhole limpet hemocyanin). The hemocyanin is purified using anion exchange chromatography.